Letters New management of gonorrhoea

Impact of antibiotic resistance

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3523 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3523
  1. Rachel Sacks, specialty doctor in genitourinary medicine/HIV1,
  2. Linda Greene, consultant in genitourinary medicine/HIV1
  1. 1Jefferiss Wing, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London W2 1NY, UK
  1. rachel.sacks{at}imperial.nhs.uk

Changes have recently been made to the British Association of Sexual Health and HIV (BASHH) guidelines on the management of Neisseria gonorrhoeae.1 2 Analysis of the UK Gonococcal Resistance to Antimicrobials Programme data showed decreasing sensitivity to cephalosporins.3 The BASHH clinical effectiveness group therefore drafted guidelines advising ceftriaxone 500 mg intramuscularly as …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe